Created at Source Raw Value Validated value
Nov. 16, 2021, 6:30 p.m. usa

inclusion criteria: age ≥ 18 years. microbiologically-confirmed sars-cov-2. clinical symptoms compatible with covid-19 for 14 days or less before randomization. oxygen saturation ≥ 95%. protein c-reactive in blood performed by point-of-care testing ≥ 20 mg/l. signed informed consent.

inclusion criteria: age ≥ 18 years. microbiologically-confirmed sars-cov-2. clinical symptoms compatible with covid-19 for 14 days or less before randomization. oxygen saturation ≥ 95%. protein c-reactive in blood performed by point-of-care testing ≥ 20 mg/l. signed informed consent.

March 14, 2021, 12:31 a.m. usa

inclusion criteria: 1. age ≥ 18 years. 2. microbiologically-confirmed sars-cov-2. 3. clinical symptoms compatible with covid-19 for 14 days or less before randomization. 4. oxygen saturation ≥ 95%. 5. protein c-reactive in blood performed by point-of-care testing ≥ 20 mg/l. 6. signed informed consent.

inclusion criteria: 1. age ≥ 18 years. 2. microbiologically-confirmed sars-cov-2. 3. clinical symptoms compatible with covid-19 for 14 days or less before randomization. 4. oxygen saturation ≥ 95%. 5. protein c-reactive in blood performed by point-of-care testing ≥ 20 mg/l. 6. signed informed consent.